Microinvasive breast carcinoma

long-term results

Authors

  • Sandra Gioia Instituto Nacional de Câncer
  • Fernanda Maria Marinho Instituto Nacional de Câncer
  • Juliana Murteira Instituto Nacional de Câncer
  • Flavia Felicio Instituto Nacional de Câncer
  • Tamara Schwartz Instituto Nacional de Câncer
  • Cristiane Torres Instituto Nacional de Câncer
  • Marcelo Bello Instituto Nacional de Câncer
  • Lidia Maria Magalhães Instituto Nacional de Câncer
  • Giselle Maria Vignal Instituto Nacional de Câncer
  • Humberto Carneiro Instituto Nacional de Câncer
  • Tatiana Alvarenga Instituto Nacional de Câncer
  • Anke Bergmann Instituto Nacional de Câncer

Keywords:

Breast cancer, Neoplasm staging, Axilla, Prognosis, Survivorship (Public Health)

Abstract

Objective: Microinvasive breast carcinoma (MBC) is an uncommon breast carcinoma subtype although an increase of screening mammography in recent decades has resulted in a higher incidence of ductal carcinoma in situ (DCIS), as well as invasive carcinomas at early stages. The objective of this research study was to review 115 cases of MBC from Brazilian National Cancer Institute between the years 2000 and 2010. Methods: The clinical presentation, diagnosis, type of treatment, clinical progression and the relevance of the axillary nodal status were analyzed. Results: The average patient age was 56 years old. Radiographic findings of calcifications on MBC lesions (68%) were similar to the findings seen on DCIS. Positive axillary metastasis was seen in 9.6% of the cases. After a follow up of on average eight years, one case of local recurrence and four cases of distal recurrence were seen. Overall survival was 95.6% and disease-free survival was 96.5%. Conclusion: Despite the possibility of nodal metastasis in our study, MBC has a favorable prognosis and it is associated with a low axillary nodal metastasis risk. Knowledge of clinical presentation and radiological findings of DCIS lesions may draw a physician’s attention to the possibility of local microinvasion and the appropriate approach for each patient.

Downloads

Download data is not yet available.

Author Biographies

Sandra Gioia, Instituto Nacional de Câncer

Serviço de Mastologia do INCA – Rio de Janeiro (RJ), Brasil.

Fernanda Maria Marinho, Instituto Nacional de Câncer

Serviço de Mastologia do INCA – Rio de Janeiro (RJ), Brasil.

Juliana Murteira, Instituto Nacional de Câncer

Serviço de Mastologia do INCA – Rio de Janeiro (RJ), Brasil.

Flavia Felicio, Instituto Nacional de Câncer

Serviço de Mastologia do INCA – Rio de Janeiro (RJ), Brasil.

Tamara Schwartz, Instituto Nacional de Câncer

Serviço de Mastologia do INCA – Rio de Janeiro (RJ), Brasil.

Cristiane Torres, Instituto Nacional de Câncer

Serviço de Mastologia do INCA – Rio de Janeiro (RJ), Brasil.

Marcelo Bello, Instituto Nacional de Câncer

Serviço de Mastologia do INCA – Rio de Janeiro (RJ), Brasil.

Lidia Maria Magalhães, Instituto Nacional de Câncer

Serviço de Patologia do INCA – Rio de Janeiro (RJ), Brasil.

Giselle Maria Vignal, Instituto Nacional de Câncer

Serviço de Patologia do INCA – Rio de Janeiro (RJ), Brasil.

Humberto Carneiro, Instituto Nacional de Câncer

Serviço de Patologia do INCA – Rio de Janeiro (RJ), Brasil.

Tatiana Alvarenga, Instituto Nacional de Câncer

Serviço de Patologia do INCA – Rio de Janeiro (RJ), Brasil.

Anke Bergmann, Instituto Nacional de Câncer

Programa de Carcinogenese Molecular do INCA – Rio de Janeiro (RJ), Brasil.

Published

2016-07-15

How to Cite

Gioia, S., Marinho, F. M., Murteira, J., Felicio, F., Schwartz, T., Torres, C., … Bergmann, A. (2016). Microinvasive breast carcinoma: long-term results. Revista Brasileira De Mastologia, 26(3), 95–101. Retrieved from https://revistamastology.emnuvens.com.br/rbm/article/view/223

Issue

Section

Original Article